These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 35766333)
41. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer. Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733 [TBL] [Abstract][Full Text] [Related]
42. The clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway. Yu ZX; Xiang C; Xu SG; Zhang YP Medicine (Baltimore); 2022 Aug; 101(31):e29972. PubMed ID: 35945747 [TBL] [Abstract][Full Text] [Related]
43. Aggregate analysis based on TCGA: TTN missense mutation correlates with favorable prognosis in lung squamous cell carcinoma. Cheng X; Yin H; Fu J; Chen C; An J; Guan J; Duan R; Li H; Shen H J Cancer Res Clin Oncol; 2019 Apr; 145(4):1027-1035. PubMed ID: 30810839 [TBL] [Abstract][Full Text] [Related]
44. Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients. Lei Q; Wang Y; Li J; Wang S; Hu Y; Duan L; Huo Y; Wu Y; Liu H Aging (Albany NY); 2023 May; 15(9):3572-3585. PubMed ID: 37155149 [TBL] [Abstract][Full Text] [Related]
45. Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies. Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J J Cancer Res Clin Oncol; 2023 Oct; 149(13):11157-11170. PubMed ID: 37347261 [TBL] [Abstract][Full Text] [Related]
46. Identification of PANoptosis-related genes as prognostic indicators of thyroid cancer. Xie D; Huang L; Li C; Wu R; Zheng Z; Liu F; Cheng H Heliyon; 2024 Jun; 10(11):e31707. PubMed ID: 38845990 [TBL] [Abstract][Full Text] [Related]
47. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
48. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer. Wang F; Chen C; Chen WP; Li ZL; Cheng H Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125 [TBL] [Abstract][Full Text] [Related]
49. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis. Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764 [TBL] [Abstract][Full Text] [Related]
50. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5. Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092 [TBL] [Abstract][Full Text] [Related]
51. Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer. Hu D; Zhou M; Zhu X Biomed Res Int; 2019; 2019():2506843. PubMed ID: 31886185 [TBL] [Abstract][Full Text] [Related]
52. New insights into COL26A1 in thyroid carcinoma: prognostic prediction, functional characterization, immunological drug target and ceRNA network. Luo Y; Ye Y; Zhang Y; Chen L; Qu X; Yi N; Ran J; Chen Y Transl Cancer Res; 2023 Dec; 12(12):3384-3408. PubMed ID: 38197076 [TBL] [Abstract][Full Text] [Related]
53. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
54. Identification of prognostic signatures associated with long-term overall survival of thyroid cancer patients based on a competing endogenous RNA network. Li X; Dai D; Wang H; Wu B; Wang R Genomics; 2020 Mar; 112(2):1197-1207. PubMed ID: 31295545 [TBL] [Abstract][Full Text] [Related]
55. Heterogeneous pattern of gene expression driven by Liu Z; Zhao X; Wang R; Tang X; Zhao Y; Zhong G; Peng X; Zhang C Front Oncol; 2023; 13():916568. PubMed ID: 37035196 [TBL] [Abstract][Full Text] [Related]
56. NKD2 is correlated with the occurrence, progression and prognosis of thyroid carcinoma. Gao Y; Wang Y; Guo R Eur J Med Res; 2022 Nov; 27(1):235. PubMed ID: 36348408 [TBL] [Abstract][Full Text] [Related]
57. CircHACE1 functions as a competitive endogenous RNA to curb differentiated thyroid cancer progression by upregulating Tfcp2L1 through adsorbing miR-346. Li X; Yang S; Zhao C; Yang J; Li C; Shen W; Hu H; Zhang W; Yang S Endocr J; 2021 Aug; 68(8):1011-1025. PubMed ID: 34092745 [TBL] [Abstract][Full Text] [Related]
58. Chemokine CCL14 affected the clinical outcome and correlated with immune infiltrates in thyroid carcinoma. Zhang MM; Zhao YD; Li Q; He YJ Histol Histopathol; 2023 Jun; 38(6):695-707. PubMed ID: 36409028 [TBL] [Abstract][Full Text] [Related]
59. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085 [No Abstract] [Full Text] [Related]
60. CAPN8 involves with exhausted, inflamed, and desert immune microenvironment to influence the metastasis of thyroid cancer. Zhong X; Xu S; Wang Q; Peng L; Wang F; He T; Liu C; Ni S; He Z Front Immunol; 2022; 13():1013049. PubMed ID: 36389799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]